App Reminder on ASA Adherence
Impact of a Smartphone App Reminder on Adherence Aspirin Prescribed as Anti-Thrombotic Therapy
1 other identifier
interventional
195
1 country
1
Brief Summary
The purpose of this study is to explore the impact of using a smartphone app reminder on medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. This study will randomly assign participants to get usual postoperative care which is teaching with verbal instructions and printed information about taking the aspirin at the time of discharge, or to have an app on your smartphone with preset reminders in addition to usual postoperative discharge teaching after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2017
CompletedFirst Posted
Study publicly available on registry
August 9, 2017
CompletedStudy Start
First participant enrolled
October 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2019
CompletedOctober 23, 2019
October 1, 2019
1.4 years
August 7, 2017
October 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of Pills Taken
The proportion of pills taken is defined as the percentage of pills taken by study participants.
Post- Operative Visit (Day 36)
Secondary Outcomes (9)
AIDS Clinical Trials Group (ACTG) Adherence Questionnaire Score
Post- Operative Visit (Day 36)
Aspirin (ASA) Self-Efficacy Scale Score
Post- Operative Visit (Day 36)
Number of Thromboembolic Events
Post- Operative Visit (Day 36)
Aspirin (ASA) General Adherence Scale Score
Post- Operative Visit (Day 36)
Unified Theory of Acceptance and Use of Technology (UTAUT2) Survey Score
Baseline (Pre-Intervention)
- +4 more secondary outcomes
Study Arms (2)
Standard Education
ACTIVE COMPARATORParticipants randomized to this arm will receive the standard education provided to patients about the importance of taking aspirin to prevent thromboembolic events after orthopedic surgery.
Medication Reminder App + Standard Education
EXPERIMENTALParticipants randomized to this arm will use a smartphone app with preset reminders to take aspirin to prevent thromboembolic events after orthopedic surgery in addition to usual postoperative discharge teaching.
Interventions
Participants will receive the usual verbal education and printed information provided to patients about the importance of taking aspirin to prevent thromboembolic events after orthopedic surgery, medication dosage and scheduling.
Participants will use a medication reminder app that is set in collaboration with the participants for times that fit into their daily lifestyle. The app will alert participants when it is time (selected by the participant) to take their medication.
Eligibility Criteria
You may qualify if:
- Prescribed aspirin 81 mg twice a day for 35 days
- Ability to write and speak English
- Have a smart phone with the capacity to download and set an app
- Own and use a smart phone for communication purposes
You may not qualify if:
- Diagnosis of mental illness
- Do not own a smart phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Association of Orthopaedic Nursescollaborator
Study Sites (1)
Emory Orthopedic and Spine Hospital
Atlanta, Georgia, 30084, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Wittig-Wells, PhD
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct Associate Professor
Study Record Dates
First Submitted
August 7, 2017
First Posted
August 9, 2017
Study Start
October 3, 2017
Primary Completion
March 8, 2019
Study Completion
March 8, 2019
Last Updated
October 23, 2019
Record last verified: 2019-10